全文获取类型
收费全文 | 96566篇 |
免费 | 7038篇 |
国内免费 | 2158篇 |
专业分类
耳鼻咽喉 | 1086篇 |
儿科学 | 3083篇 |
妇产科学 | 1108篇 |
基础医学 | 8440篇 |
口腔科学 | 1454篇 |
临床医学 | 12193篇 |
内科学 | 17583篇 |
皮肤病学 | 1164篇 |
神经病学 | 2670篇 |
特种医学 | 1624篇 |
外国民族医学 | 3篇 |
外科学 | 9595篇 |
综合类 | 15937篇 |
现状与发展 | 7篇 |
一般理论 | 2篇 |
预防医学 | 13605篇 |
眼科学 | 447篇 |
药学 | 8834篇 |
80篇 | |
中国医学 | 4750篇 |
肿瘤学 | 2097篇 |
出版年
2024年 | 213篇 |
2023年 | 1534篇 |
2022年 | 3110篇 |
2021年 | 4376篇 |
2020年 | 4095篇 |
2019年 | 3423篇 |
2018年 | 3318篇 |
2017年 | 3336篇 |
2016年 | 3725篇 |
2015年 | 3848篇 |
2014年 | 7449篇 |
2013年 | 7600篇 |
2012年 | 6787篇 |
2011年 | 7238篇 |
2010年 | 5385篇 |
2009年 | 4812篇 |
2008年 | 4413篇 |
2007年 | 4464篇 |
2006年 | 4026篇 |
2005年 | 3420篇 |
2004年 | 2713篇 |
2003年 | 2319篇 |
2002年 | 1712篇 |
2001年 | 1534篇 |
2000年 | 1297篇 |
1999年 | 1212篇 |
1998年 | 933篇 |
1997年 | 840篇 |
1996年 | 755篇 |
1995年 | 715篇 |
1994年 | 686篇 |
1993年 | 542篇 |
1992年 | 505篇 |
1991年 | 461篇 |
1990年 | 409篇 |
1989年 | 377篇 |
1988年 | 315篇 |
1987年 | 239篇 |
1986年 | 201篇 |
1985年 | 246篇 |
1984年 | 193篇 |
1983年 | 134篇 |
1982年 | 159篇 |
1981年 | 117篇 |
1980年 | 125篇 |
1979年 | 99篇 |
1978年 | 69篇 |
1977年 | 71篇 |
1976年 | 71篇 |
1975年 | 33篇 |
排序方式: 共有10000条查询结果,搜索用时 234 毫秒
1.
目的 探讨糖尿病合并结核潜伏感染的研究现状、热点与前沿。方法 收集Web of Science核心合集于2000年1月1日至2021年11月20日发表的糖尿病合并结核潜伏感染的相关文章,运用CiteSpace 5.8.R3软件进行可视化分析。结果 共纳入英文文献148篇,近20年来该领域发文量呈上升趋势。美国发文量最多(46篇, 31.08%),机构间合作情况的可视化分析共得到个340节点、929条连线,网络密度为0.0161,作者间合作关系的知识图谱共得到790个节点、2425条连线,网络密度为0.0078,关键词共现分析结果显示,糖尿病合并结核潜伏感染的危险因素、患病率、诊断和治疗是该领域的研究热点和趋势。结论 糖尿病合并结核潜伏感染的发文量不断增加,机构间、区域内和国际范围内的合作有待进一步开展。立足国情,探索慢病共病的管理模式将有助于优化共病管理,进一步推动慢病管理的进程。 相似文献
2.
3.
《Archivos de bronconeumología》2022,58(1):11-21
BackgroundWe aimed to describe the effectiveness and safety of inhaled antibiotics in chronic obstructive pulmonary disease (COPD) patients, as well as the patient profile in which they are usually prescribed and the patient groups that can most benefit from this treatment.MethodsMulticentre retrospective observational cohort study in COPD patients who had received ≥1 dose of inhaled antibiotics in the last 5 years. Clinical data from the two years prior to and subsequent to the start of the treatment were compared. Primary outcome: COPD exacerbations. Secondary outcomes: side effects, symptomatology (sputum purulence, dyspnoea), microbiological profile and pathogen eradication.ResultsOf 693 COPD patients analyzed (aged 74.1; 86.3% men; mean FEV1 = 43.7%), 71.7% had bronchiectasis and 46.6% presented chronic bronchial infection (CBI) by Pseudomonas aeruginosa (PA). After 1 year of treatment with inhaled antibiotics, there was a significant decrease in the number of exacerbations (?33.3%; P < .001), hospital admissions (?33.3%; P < .001) and hospitalization days (?26.2%; P = .003). We found no difference in effectiveness between patients with or without associated bronchiectasis. Positive patient outcomes were more pronounced in PA-eradicated patients. We found a significant reduction in daily expectoration (?33.1%; P = .024), mucopurulent/purulent sputum (?53.9%; P < .001), isolation of any potentially pathogenic microorganisms (PPM) (?16.7%; P < .001), CBI by any PPM (?37.4%; P < .001) and CBI by PA (?49.8%; P < .001). CBI by any PPM and ≥three previous exacerbations were associated with a better treatment response. 25.4% of patients presented non-severe side-effects, the most frequent of these being bronchospasm (10.5%), dyspnoea (8.8%) and cough (1.7%).ConclusionsIn COPD patients with multiple exacerbations and/or CBI by any PPM (especially PA), inhaled antibiotics appear to be an effective and safe treatment, regardless of the presence of bronchiectasis. 相似文献
4.
We present the case of a male patient with severe SARS-CoV-2 pneumonia, with simultaneous onset of p-ANCA positive rapidly progressive glomerulonephritis. We discuss the different therapeutic possibilities, emphasising the appropriateness of their administration according to the time in the course of the infection. 相似文献
5.
目的探讨慢性泪囊炎患者应用鼻内镜下鼻腔泪囊造口术的临床效果及安全性。方法选取2018年1月至2019年12月因慢性泪囊炎于本院接受治疗的46例患者为研究对象,随机分为研究组与对照组,各23例。对照组接受泪囊鼻腔造口治疗,研究组取鼻内镜下鼻腔泪囊造口术治疗,比较两组临床效果、手术指标以及并发症发生情况。结果研究组治疗总有效率高于对照组(P<0.05);研究组术中出血量少于对照组,手术及住院时间均短于对照组(P<0.05);研究组并发症总发生率低于对照组(P<0.05)。结论慢性泪囊炎患者采用鼻内镜下鼻腔泪囊造口术治疗效果显著,并发症较少,安全性较高,值得临床推广应用。 相似文献
6.
Behzad Emadi Mojtaba Ghahraman Rezaieh Mansour Sedighi 《Transfusion and apheresis science》2021,60(3):103132
Transfusion transmissible infections (TTIs) have been a public health challenge for the accessibility, quality and safety of blood transfusion. The present study aimed to consider the prevalence and the trends of hepatitis B virus (HBV), hepatitis C virus (HCV), Human T-cell leukemia virus type 1 (HTLV-1), human immunodeficiency virus (HIV) and syphilis across the ten years among retrospective blood donors. A retrospective investigation of blood donors’ data covering the period from 22 May 2009 to 22 May 2019 was done. Data was accumulated and analyzed from Blood Transfusion Center records, pertaining to all donors who were screened for various TTIs using respective immunological techniques. Out of the 682,171 screened donors in the 2009–2019 study period, 2470 (0.36 %) were infected with at least one infectious agent. The overall prevalence of HBV, HCV, HTLV-1, HIV and syphilis were 1700 (0.25 %), 184 (0.027 %), 335 (0.05 %), 4 (0.0.05 %) and 247 (0.036 %), respectively. The study showed male dominated donor pool (96.79 %) with higher prevalence (0.34 %) of TTIs compared to female donors (0.02 %) with 3.21 % population. Despite the low prevalence of TTIs in our study, HBV, HCV, syphilis and HIV have remained a big threat to safe blood transfusion in Iran. Strict adherence to selection criteria, algorithm of donor screening, use of highly sensitive and specific methods for detection of TTIs, regular consultation and health education programs, prevention and sanitization strategies to reduce the risk of TTIs are recommended to reduce the risk of TTIs and ensure the safety of blood transfusion for recipient. 相似文献
7.
8.
9.
10.